Nevro

Nevro is focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Nevro is a publicly traded company with a strong product portfolio, both digital and hardware. Tech stack: terraform (AWS provider). Development teams work in .Net Core (2.2->6.0preview), .Net Framework 4.8.2, swift, kotlin Building a core platform team to support R&D and help patients with their chronic pain: